Treatment of cutaneous leishmaniasis: retrospectives and advances for the 21st century
Open Access
- 1 May 1999
- journal article
- review article
- Published by Elsevier in Clinics in Dermatology
- Vol. 17 (3) , 305-315
- https://doi.org/10.1016/s0738-081x(99)00049-8
Abstract
No abstract availableThis publication has 104 references indexed in Scilit:
- Leishmaniasis: Recent advances in treatmentJournal of the American Academy of Dermatology, 1997
- A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in TurkeyInternational Journal of Dermatology, 1997
- Topical treatment of New World cutaneous leishmaniasis in Belize: A clinical studyJournal of the American Academy of Dermatology, 1993
- Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United KingdomTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, IndiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control studyJournal of the American Academy of Dermatology, 1992
- Studies on the leishmaniases in the Sudan. 2. Clinical and parasitological studies on cutaneous leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- Aryl-2 et alkyl-2 quinoléines nouvelles isolées d'une Rutacée bolivienne: GalipealongifloraCanadian Journal of Chemistry, 1989
- Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimonyBritish Journal of Dermatology, 1988
- Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam)Journal of the American Academy of Dermatology, 1986